alexa An update on mortality in systemic lupus erythematosus.
Immunology

Immunology

Rheumatology: Current Research

Author(s): Ippolito A, Petri M

Abstract Share this page

Abstract OBJECTIVE: Both systemic lupus erythematosus (SLE) and its treatments can contribute to increased mortality rates. The main focus of this review is recent studies on mortality during the last 5 years. METHODS: A literature search using PUBMED was performed for articles relating to lupus mortality with a specific focus on literature published within the last 5 years. RESULTS: Survival rates for lupus patients have improved greatly with the ability to treat disease-specific manifestations and infections and to lessen the impact of comorbid conditions. Nonetheless, disparities in mortality rates still exist based on ethnicity, socioeconomic status, age, and gender. Cardiovascular disease, infection, and severe disease activity remain common causes of mortality. CONCLUSIONS: Despite advances in the treatment of SLE-associated infection, and renal failure, increased mortality remains a major concern in patient management.
This article was published in Clin Exp Rheumatol and referenced in Rheumatology: Current Research

Relevant Expert PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords